Countries
Industry
Startup stage
Startup size
Funding
Impact startup SDGs
Showing: 2273 filtered startups

Fromber

Forretningsidé Tenk hvor mye ubenyttet kunnskap vi har. Fromber er en digital plattform for privatundervisning som gjennom ny teknologi og forretningsmodell tilbyr billigere, lettere tilgjengelig og større effekt av det du ønsker å lære mer av. Med Fromber kan du som bruker lære mer og som talent hjelpe andre å bli bedre, med formål om å ta ett skritt frem med en som er ett skritt foran. Fromber er derfor både et marked som verdsetter din kunnskap og et sentrum for læring. Mål: Bli sentrum for all privatundervisning i Norge, for så å ekspandere til Norden. Deretter Europa og tilslutt å innta en identisk posisjon som Uber har for taxi, gjennom privatundervisning, tilgjengelig for mennesker i alle deler av verden. Visjon: Fromber har en visjon om å gjøre privatundervisning tilgjengelig for alle.

Entro

Entro is an energy- and environmental consultancy firm with two clients – our customers and the environment. We save our customers time and money, and we help the environment by reducing energy consumption and carbon footprints. Entro has about 60 employees in Oslo, Trondheim, and Bergen. We had a turnover of NOK 63 million in 2016 and saved our customers NOK 400 million. Entro has a unique interdisciplinary expertise with a good mix of practical and academic skills. Among our staff we have more trade certificates in electrical and construction, more than 60% of the employees are civil engineers and engineers and we have several employees with training in economics and management. We have expertise in electrical, plumbing, building, environment, and IT.

Medsensio

Medsensio will develop educational, clinical, and monitoring tools by analyzing medical data using machine learning and statistics. Our first project is developing an auscultation learning tool for students. Students will be able to verify their own interpretations of lung sounds using our machine-learning technology

Pharmasum Therapeutics AS

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Gruten AS

Gruten is an Oslo-based company that creates new value and meaning from coffee waste. We use coffee grounds in the production of soap and body scrub, and run an educational program with lectures, courses, and workshops to create awareness and knowledge about coffee grounds as a valuable resource.  We have a small production/workshop/outlet at Torshov, and sell our products on our own webshop + in ca 35 stores around Oslo and the rest of Norway. At the moment we are working hard to set up a site for mushroom production, growing oyster mushrooms on coffee grounds. When we get a go-ahead for this we will be in demand for funding to set up the production site (we will be growing in used cooling containers, so-called reefers) and need people to work on the site.

Halify AS

Halify AS operates on markets within the field of urban spatial area management, with a specific focus on Intelligent Transport Systems (ITS) and urban mobility. We have supplied solutions for Horizon2020-funded projects (VICINITY, CrossMove, BIG IoT), and received support from the Research Council of Norway on projects like Komét and Sparkling, and cooperated with the NCE environment in Horten and Oslo. We are active within several consortiums and part of the Smart Cities Norway network, the ENIT network, and ITS Arena. We have developed solutions for calculating and visualizing the environmental impact made by the transport industry on Norwegian municipalities, and take pride in visualizing difficult concepts and results in a way that is easy to convey.

Optimeering Aqua AS

BioPlan optimizes production planning for all steps in the aquaculture value chain, from roe to harvest.BioPlan's algorithms represent the state-of-the-art in production optimization. They are the result of many years of in-depth research and development, both in-house and at the Norwegian University of Science and Technology in Trondheim, Norway. BioPlan is today used for planning salmon production with an annual sales value of 4 billion NOKOfficial launched of software in August 2017. Now building a customer base

AquaPro

Om prosjektet – fra slam til brenselDet skal bygges og utvikles et mobilt prosessanlegg som gjør slam/avfall fra havbruksnæringen om til brennbart materiale.Brenselet vil det ha et stort potensiale i sementproduksjon eller fjernvarmeanlegg. Vi vil også selge tørket slam tilbake til havbruksnæringen/oppdrettsanlegg som energi. Prosjektet er i oppstartsfasen og skal ha fokus på teknologiutvikling, samt etablering av løsninger for slamhåndtering, mat- og bioavfall.Våre kunder er klekkerier, smoltanlegg, testanlegg i sjø (lukkede merder), sementproduksjon, fjernvarmeanlegg. Vi har og det samme segmentet i utlandsmarkedet.

A7 Europe AS

A7 was founded in USA late 2015. It was started as a movement dedicated to helping others reaching their full potensial. On the back of all the shirts there is a patented grip that prevents the bar from sliding when you do squats. When you do bench it keeps your body from sliding. Its usable for many other purposes in training as well but that´s the two big ones. 2016 was a true adventure for the Europe company.

GoActive

GoActive aims to be the most environmentally friendly fitness and activity organization in the market. GoActive offers different courses with Personal Trainers in Groups. The basis for all hours is based on Body Weight training (BWT) and High Intensive Interval training (HIIT). On this basis, then all matter prerequisite participants - our instructors will adapt and adjust your bet according to your level. We work closely with experts like doctors, chiropractors, and physical therapists.

Naturbit

Naturbit er et nytt frokost- og mellommåltidskonsept rettet mot personer som er ute etter et enkelt, rimelig og næringsrikt alternativ til dagens produkter. Ved å ta i bruk naturlige ingredienser, uten bruk av tilsetningsstoffer og tilsatt sukker, har vi utviklet produkter innenfor kategoriene granola, hurtiggrøter, energibarer, nøttemikser og frømikser. Vi har fokusert på å lage oppskrifter av høy kvalitet, med fokus på gode råvarer og forpakning tilpasset forbrukere på farta. Naturbit skal gjøre det enklere for folk å spise næringsrik mat i en travel hverdag.

Innowin AS

INNOWIN delivers premium advisory and execution support within innovation and R&D. We help companies to build innovation capacity and create profitable growth through better innovation strategies, improved execution, and successful project funding. We merge creativity, market insights, and technology knowledge to solve complex challenges together with our customers. Our consultants have extensive experience in business development, operations, and project management. INNOWIN is a strategic business partner in all stages of your journey - from strategy and concept to project and execution to implementation and launch. We help companies to gain and sustain a winning position.

ESG-NRG

Through ESG-NRG's Marine Offset Platform (MOP) we enable the maritime transportation industry to easily calculate their vessel emissions, neutralize their CO2 impact with our independently rated database of carbon projects, and demonstrate their commitment to Net Zero on our public carbon ledger.

Infobric Fleet

We develop digital solutions that make everyday life easier, offer decision-making support, and increase profitability for companies where vehicles, machines and equipment are an important part of business. Ease Fleet is a digital platform with solutions that make owning vehicles, machines and equipment easier. Welcome to a World of Ease.

Investorweb

Investorweb is a LinkedIn like platform for the stock market. We amplify public companies investor relations efforts by making it easier for investors to stay updated. Public companies no longer need to juggle multiple platforms. On Investorweb, investors, analysts and journalists will actively search for public companies and find relevant information.